1246PDTalimogene laherparepvec (T-VEC) treatment increases intratumoral effector T-cell and natural killer (NK) cell density in noninjected tumors in patients (pts) with stage IIIB–IVM1c melanoma: Evidence for systemic effects in a phase II, single-arm study. (23rd October 2018) - Gogas, H; Samoylenko, I; Schadendorf, D; Gutzmer, R; Grob, J J; Sacco, J J; Gorski, K; Anderson, A; Liu, C; Malvehy, J